Rheumatoid Arthritis and Psoriasis Drug will be Commercialize by Abbot and Biotest - AccentedTouch

AccentedTouch Rheumatoid Arthritis and Psoriasis Drug faculty be Commercialize by superior and Biotest AccentedTouch According to the Abbott Laboratories news, it has made a global agreement with the Biotest AG to do development and tap the BT-061, which is a novel anti-CD4 antibody for the treatment of rheumatoid arthritis and disease of the skin . ... Link To Article